DeepMed Research

Columbia University

🇺🇸United States

Country: 🇺🇸United States

Ownership: Private

Established: 1754-01-01

Employees: 20.8K

Market Cap: -

Website: https://www.arch.columbia.edu

Clinical Trials

Rifaximin for the Treatment of Persistent Symptoms in Patients With Celiac Disease

Not Applicable

Completed

Conditions: Celiac Disease

Interventions: Drug: Placebo
Drug: Rifaximin

First Posted Date: 2010-06-07

Last Posted Date: 2022-06-29

Lead Sponsor: Columbia University

Target Recruit Count: 50

Registration Number: NCT01137955

Locations: 🇺🇸
Celiac Disease Center at Columbia University, New York, New York, United States

Acetaminophen in Combination With N-Acetylcysteine (NAC) Versus Placebo in Treating Fever

Not Applicable

Withdrawn

Conditions: Liver Failure
Liver Failure, Acute
Fever
Prevention & Control
Drug Induced Liver Injury

Interventions: Drug: APAP and Placebo
Drug: APAP and NAC combination

First Posted Date: 2010-06-04

Last Posted Date: 2015-03-05

Lead Sponsor: Columbia University

Registration Number: NCT01137591

Locations: 🇺🇸
Columbia University Medical Center, New York, New York, United States

Fundic Gland Polyps and Proton Pump Inhibitor (PPI) Drugs

Terminated

Conditions: Fundic Gland Polyps

First Posted Date: 2010-05-26

Last Posted Date: 2012-07-02

Lead Sponsor: Columbia University

Target Recruit Count: 23

Registration Number: NCT01130363

Locations: 🇺🇸
Columbia University Medical Center, New York, New York, United States

Treatment of Resistant Nephrotic Syndrome With ACTH Gel (ACTHAR)

Phase 4

Completed

Conditions: Treatment Resistant Nephrotic Syndrome

Interventions: Drug: ACTHAR gel

First Posted Date: 2010-05-24

Last Posted Date: 2014-04-24

Lead Sponsor: Columbia University

Target Recruit Count: 15

Registration Number: NCT01129284

Locations: 🇺🇸
Columbia University Medical Center, New York, New York, United States

Aldosterone Breakthrough During Diovan, Tekturna, and Combination Therapy in Patients With Proteinuric Kidney Disease

Phase 4

Terminated

Conditions: Proteinuric Kidney Disease
Diabetic Nephropathy
Hypertensive Nephrosclerosis
IgA Nephropathy
Focal Segmental Glomerulosclerosis
Glomerulopathy (Obesity-associated)
Glomerulonephritis, Membranous

Interventions: Drug: Aliskiren
Drug: Valsartan

First Posted Date: 2010-05-24

Last Posted Date: 2014-05-15

Lead Sponsor: Columbia University

Target Recruit Count: 46

Registration Number: NCT01129557

Locations: 🇺🇸
Columbia University Medical Center, New York, New York, United States

Botulinum Toxin as a Novel Treatment for Prevention of Post-Traumatic Elbow Stiffness

Not Applicable

Completed

Conditions: Post Traumatic Stiffness

Interventions: Drug: Botulinum Toxin Type A
Drug: Saline

First Posted Date: 2010-05-24

Last Posted Date: 2015-03-27

Lead Sponsor: Columbia University

Target Recruit Count: 18

Registration Number: NCT01129583

Locations: 🇺🇸
Columbia University Medical Center, New York, New York, United States

Frequency of Methods of Local Invasion of Pancreatic Adenocarcinoma

Completed

Conditions: Pancreatic Cancer

First Posted Date: 2010-05-24

Last Posted Date: 2023-03-17

Lead Sponsor: Columbia University

Target Recruit Count: 1052

Registration Number: NCT01129167

Locations: 🇺🇸
Columbia University Irving Medical Center, New York, New York, United States

Millennium Villages Project in Sub-Saharan Africa

Not Applicable

Completed

Conditions: Child Survival

Interventions: Other: Routine services
Other: Health and development intervention package

First Posted Date: 2010-05-18

Last Posted Date: 2017-04-21

Lead Sponsor: Columbia University

Target Recruit Count: 65000

Registration Number: NCT01125618

Locations: 🇳🇬
Pampaida, Pampaida, Nigeria
🇸🇳
Potou, Potou, Senegal
🇬🇭
Bonsasso, Bonsasso, Ghana

and more 8 locations

Use of PET Imaging to Distinguish Malignant From Benign IPMN

Not Applicable

Terminated

Conditions: Neoplasm
Pancreatic Cancer

Interventions: Radiation: [18F]-FDG PET/CT imaging

First Posted Date: 2010-04-15

Last Posted Date: 2016-09-15

Lead Sponsor: Columbia University

Target Recruit Count: 1

Registration Number: NCT01104116

Locations: 🇺🇸
Columbia University Medical Center, New York, New York, United States

Stool Testing for Pancreatic Cancer

Completed

Conditions: Pancreatic Cancer

First Posted Date: 2010-04-15

Last Posted Date: 2021-01-19

Lead Sponsor: Columbia University

Target Recruit Count: 158

Registration Number: NCT01104129

Locations: 🇺🇸
Columbia University Medical Center, New York, New York, United States

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy